trifluoperazine has been researched along with Delusional Disorder in 28 studies
Delusional Disorder: Disorder with presentation of a facade of coldness with characteristic pervasive mistrust and suspiciousness of others.
Excerpt | Relevance | Reference |
---|---|---|
"A combined analysis of data from 11 controlled studies of loxapine versus either chlorpromazine or trifluoperazine in acute schizophrenia (5 studies) and chronic schizophrenia (6 studies) showed statistically significant superiority of loxapine on several items and factors of standardized psychiatric rating scales." | 9.04 | Efficacy of loxapine in the treatment of paranoid schizophrenia. ( Bishop, MP; Dunnett, CW; Kiltie, H; Simpson, GM, 1977) |
"A combined analysis of data from 11 controlled studies of loxapine versus either chlorpromazine or trifluoperazine in acute schizophrenia (5 studies) and chronic schizophrenia (6 studies) showed statistically significant superiority of loxapine on several items and factors of standardized psychiatric rating scales." | 5.04 | Efficacy of loxapine in the treatment of paranoid schizophrenia. ( Bishop, MP; Dunnett, CW; Kiltie, H; Simpson, GM, 1977) |
"Clinical experience gained in the Soviet Union shows that Triphthazine (Trifluoperazine) is among the most useful drugs for mass treatment of psychoses." | 3.65 | [Use of triphthazine in the treatment of mentae disorders]. ( Awruzki, GJ; Gurowitsch, IJ, 1975) |
" schedule) had demonstrable anti-psychotic activity in 14 of 25 chronic schizophrenic patients (56%), while TFP treatment in appropriate dosage showed a similar activity in 9 of 23 patients (39%)." | 2.64 | A double-blind comparison of loxitane--loxapine succinate and trifluoperazine hydrochloride in chronic schizophrenic patients. ( Moyano, CZ, 1975) |
" An experimental study of the long-term administrations of haloperidol revealed the formation of adaptation to the drug which can be overcome by a zigzag-like sharp elevation of the dosage followed by rapid reduction to the baseline level." | 1.27 | [Various methods of overcoming secondary resistance to treatment developing in relation to adaptation to psychotropic drugs during long-term treatment (clinico-experimental study)]. ( Allikmets, LKh; Avrutskiĭ, GIa; Beliakov, AV; Neduva, AA; Zharkovskiĭ, AM, 1984) |
"Diminution of catalepsy was explained by a decrease of the blocking effect of the neuroleptic on the dopamine system." | 1.27 | [Adaptation to neuroleptic preparations and several ways of combatting it (experimental study)]. ( Beliakov, AV; Matvienko, OA; Neduva, AA; Zharkovskiĭ, AM, 1985) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 22 (78.57) | 18.7374 |
1990's | 2 (7.14) | 18.2507 |
2000's | 1 (3.57) | 29.6817 |
2010's | 3 (10.71) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Sadananda, SK | 1 |
Holla, B | 1 |
Viswanath, B | 1 |
Narasimha, A | 1 |
Sebastian, A | 1 |
Math, SB | 1 |
Chandrashekar, CR | 1 |
Ajiboye, PO | 1 |
Yusuf, AD | 1 |
Issa, BA | 1 |
MACDONALD, R | 1 |
WATTS, TP | 1 |
WILSON, IC | 1 |
McKAY, J | 1 |
SANDIFER, MG | 1 |
BOND, IK | 1 |
Howes, O | 1 |
Smith, S | 1 |
O'Brien, CP | 1 |
DiGiacomo, JN | 1 |
Webb, W | 1 |
Avrutskiĭ, GIa | 2 |
Allikmets, LKh | 1 |
Neduva, AA | 2 |
Zharkovskiĭ, AM | 2 |
Beliakov, AV | 2 |
Sampath, G | 1 |
Pandurangi, AK | 1 |
Marilov, VV | 1 |
Bishop, MP | 1 |
Simpson, GM | 1 |
Dunnett, CW | 1 |
Kiltie, H | 1 |
Moyano, CZ | 1 |
Gurowitsch, IJ | 1 |
Awruzki, GJ | 1 |
Sheppard, C | 1 |
Beyel, V | 1 |
Moan, E | 1 |
Fracchia, J | 1 |
Merlis, S | 1 |
Surawicz, FG | 1 |
Banta, R | 1 |
Mishanich, II | 2 |
Turianitsa, IM | 2 |
Pashchenko, AE | 1 |
Rostoka, LM | 2 |
Iliushina, SN | 1 |
Berry, T | 1 |
Raines, JM | 1 |
Greenspan, D | 1 |
Cadieux, RJ | 1 |
Kales, JD | 1 |
Kales, A | 1 |
Biever, J | 1 |
Mann, LD | 1 |
Matvienko, OA | 1 |
Perales, JA | 1 |
Garcia, A | 1 |
Infantes, V | 1 |
Valle, G | 1 |
Gurovich, IIa | 1 |
Prokhorova, IS | 1 |
Tirkel'taub, IuA | 1 |
Romanov, IuD | 1 |
Meltzer, HY | 1 |
Sachar, EJ | 1 |
Frantz, AG | 1 |
Bankier, RG | 1 |
Wijsenbeek, H | 1 |
Steiner, M | 1 |
Goldberg, SC | 1 |
Liberman, RP | 1 |
Davis, J | 1 |
Moon, W | 1 |
Moore, J | 1 |
7 trials available for trifluoperazine and Delusional Disorder
Article | Year |
---|---|
Management of hostile, suspicious patients. Trifluoperazine versus haloperidol.
Topics: Adult; Antipsychotic Agents; Disruptive, Impulse Control, and Conduct Disorders; Double-Blind Method | 1974 |
Efficacy of loxapine in the treatment of paranoid schizophrenia.
Topics: Adult; Brief Psychiatric Rating Scale; Chlorpromazine; Clinical Trials as Topic; Dibenzoxazepines; D | 1977 |
A double-blind comparison of loxitane--loxapine succinate and trifluoperazine hydrochloride in chronic schizophrenic patients.
Topics: Adult; Alkaline Phosphatase; Blood Pressure; Brief Psychiatric Rating Scale; Clinical Trials as Topi | 1975 |
[Comparative study of clothiapine and trifluoperazine in acute episodes of paranoid schizophrenia].
Topics: Acute Disease; Administration, Oral; Adult; Dibenzothiazepines; Drug Evaluation; Female; Humans; Inj | 1974 |
A comparison of fluspirilene and trifluoperazine in the treatment of acute schizophrenic psychosis.
Topics: Adult; Clinical Trials as Topic; Female; Humans; Hydrocarbons, Halogenated; Leukocyte Count; Liver F | 1973 |
Trifluoperazine: a comparison between regular and high doses.
Topics: Adolescent; Adult; Analysis of Variance; Basal Ganglia Diseases; Clinical Trials as Topic; Dose-Resp | 1974 |
Research design for analyzing drug-environment-behavior interactions.
Topics: Adult; Behavior Therapy; Chlorpromazine; Environment; Evaluation Studies as Topic; Extinction, Psych | 1973 |
21 other studies available for trifluoperazine and Delusional Disorder
Article | Year |
---|---|
Effectiveness of electroconvulsive therapy for drug-induced parkinsonism in the elderly.
Topics: Antipsychotic Agents; Dyskinesia, Drug-Induced; Electroconvulsive Therapy; Humans; Male; Middle Aged | 2013 |
Monosymptomatic Hypochondriacal Psychosis (somatic delusional disorder): a report of two cases.
Topics: Adult; Affective Disorders, Psychotic; Amitriptyline; Antidepressive Agents, Tricyclic; Antipsychoti | 2013 |
Delusional disorder-somatic type (or body dysmorphic disorder) and schizophrenia: a case report.
Topics: Adult; Antipsychotic Agents; Body Dysmorphic Disorders; Comorbidity; Humans; Male; Schizophrenia, Pa | 2010 |
Trifluoperazine dihydrochloride (stelazine) in paranoid schizophrenia.
Topics: Humans; Paranoid Disorders; Phenothiazines; Schizophrenia, Paranoid; Trifluoperazine | 1959 |
A double-blind trial to investigate the effects of Thorazine (Largactil, chlorpromazine), Compazine (Stemetil, prochlorperazine) and Stelazine (trifluoperazine) in paranoid schizophrenia.
Topics: Chlorpromazine; Double-Blind Method; Prochlorperazine; Schizophrenia; Schizophrenia, Paranoid; Tranq | 1961 |
PARANOID SCHIZOPHRENIA IN A PATIENT WITH KLINEFELTER'S SYNDROME.
Topics: Convulsive Therapy; Drug Therapy; Electroconvulsive Therapy; Homosexuality; Humans; Klinefelter Synd | 1964 |
Alendronic acid for antipsychotic-related osteopenia.
Topics: Alendronate; Antipsychotic Agents; Bone Diseases, Metabolic; Female; Haloperidol; Humans; Middle Age | 2004 |
[Various methods of overcoming secondary resistance to treatment developing in relation to adaptation to psychotropic drugs during long-term treatment (clinico-experimental study)].
Topics: Adult; Animals; Catalepsy; Corpus Striatum; Disease Models, Animal; Drug Therapy, Combination; Drug | 1984 |
Bilateral ulnar nerve paralysis: an unreported complication of drug-induced extrapyramidal rigidity.
Topics: Antipsychotic Agents; Basal Ganglia Diseases; Female; Humans; Middle Aged; Paralysis; Schizophrenia, | 1997 |
[The Dolittle syndrome].
Topics: Adult; Animals; Antipsychotic Agents; Birds; Cats; Female; Hallucinations; Haloperidol; Humans; Schi | 1997 |
[Use of triphthazine in the treatment of mentae disorders].
Topics: Chlorpromazine; Hallucinations; Humans; Long-Term Care; Mental Disorders; Psychotic Disorders; Schiz | 1975 |
Comparative survey of psychiatrists' prescription preferences: New York and Texas.
Topics: Adolescent; Adult; Aged; Antidepressive Agents; Chlorpromazine; Drug Prescriptions; Drug Therapy, Co | 1975 |
Lycanthropy revisited.
Topics: Adult; Delusions; Depersonalization; Hallucinations; Humans; Lysergic Acid Diethylamide; Male; Neuro | 1975 |
[Free amino acids and the total middle molecule fraction of the blood serum in patients with continuously progressive paranoid schizophrenia undergoing treatment].
Topics: Adult; Aging; Amino Acids; Chlorpromazine; Drug Therapy, Combination; Humans; Middle Aged; Molecular | 1988 |
[Middle-molecule spectrum of the blood serum in patients with a continuously progressive paranoid form of schizophrenia undergoing treatment].
Topics: Chlorpromazine; Chromatography, Gel; Drug Therapy, Combination; Humans; Molecular Weight; Peptides; | 1988 |
L-dopa for the negative symptoms of schizophrenia.
Topics: Drug Therapy, Combination; Humans; Levodopa; Schizophrenia; Schizophrenia, Paranoid; Schizophrenic P | 1988 |
Clonazepam in the treatment of chronic schizophrenia.
Topics: Adult; Clonazepam; Drug Therapy, Combination; Female; Fluphenazine; Humans; Lithium; Male; Middle Ag | 1987 |
Pharmacologic and psychotherapeutic issues in coexistent paranoid schizophrenia and narcolepsy: case report.
Topics: Adaptation, Psychological; Adult; Combined Modality Therapy; Dyskinesia, Drug-Induced; Fluphenazine; | 1985 |
[Adaptation to neuroleptic preparations and several ways of combatting it (experimental study)].
Topics: Animals; Apomorphine; Catalepsy; Drug Therapy, Combination; Drug Tolerance; Haloperidol; Male; Mice; | 1985 |
[Sudden cessation of psychotropic drugs].
Topics: Adolescent; Adult; Amitriptyline; Antidepressive Agents; Bipolar Disorder; Blood Pressure; Chlorprom | 1974 |
Serum prolactin levels in newly admitted psychiatric patients.
Topics: Acute Disease; Bipolar Disorder; Chicago; Chlorpromazine; Chronic Disease; Depression; Dose-Response | 1974 |